Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Revive Therapeutics Ltd. C.RVV

Alternate Symbol(s):  RVVTF

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics for rare disorders and infectious diseases. The Company is exploring the use of Bucillamine for the treatment of infectious diseases, with an initial focus on severe influenza and COVID-19. Through its subsidiary, Psilocin Pharma Corp., the Company is... see more

CSE:RVV - Post Discussion

Revive Therapeutics Ltd. > FDA website
View:
Post by GrandpaTrader on Jul 25, 2020 8:03pm

FDA website

If we do not hear a response by Thursday, Revive will automatically go into phase 3. Check out the options below and the link to FDA

An IND application may go into effect:

  • 30 days after FDA receives the application, unless FDA notifies the sponsor that the investigations described in the application are subject to a Clinical Hold; or

  • on earlier notification by FDA that the clinical investigations in the IND may begin. 

Once an IND application is in effect, a drug manufacturer may ship the investigational new drug to the investigator(s) named in the application. An investigator may not administer an investigational new drug to human subjects until the IND application goes into effect.




https://www.fda.gov/drugs/investigational-new-drug-ind-application/ind-application-procedures-overview?fbclid=IwAR3QnD5nxvSWsbwH6dPwX9dKiKi7gvfkiKXopbgcgD4D2cQPneOnlIyjIJw
Comment by Jericomile on Jul 25, 2020 8:16pm
Thank you for the post! Very informative.
Comment by pinkfloyd90 on Jul 25, 2020 8:35pm
hahahah..i just sent you an etransfer...happy Saturday Bro...thanks for everything.....I made it on that cannabis stock you told me about 3 weeks ago....ngw closed at .24 .I grabbed a boat load at .13 once rvv goes....you can have my 2 year old mustang...not that you need it...hahaha...
Comment by Chrisxd5 on Jul 26, 2020 9:31am
Can I have your stang pls? I love mustangs 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities